Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children

Bone Marrow Transplant. 2014 Dec;49(12):1538-40. doi: 10.1038/bmt.2014.182. Epub 2014 Aug 18.

Authors

D Zama¹, R Masetti¹, D M Cordelli², F Vendemini¹, L Giordano³, G Milito³, E Franzoni², F Porta⁴, A Prete¹, R Rondelli¹, A Pession¹

Affiliations

¹ Pediatric Oncology and Haematology Unit "Lalla Seràgnoli", Departement of Pediatrics, University of Bologna Sant'Orsola-Malpighi Hospital, Bologna, Italy.
² Pediatric Neurology Unit, University of Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
³ Child Neuropsychiatry, Regional Epilepsy Center, Brescia, Italy.
⁴ Pediatric Oncology-Haematology and BMT Unit, Ospedale dei Bambini, Spedali Civili, Brescia, Italy.

PMID: 25133894
DOI: 10.1038/bmt.2014.182

No abstract available

Publication types

Letter

MeSH terms

Child
Child, Preschool
Female
Hematologic Diseases / complications
Hematologic Diseases / therapy*
Hematopoietic Stem Cell Transplantation / adverse effects*
Humans
Infant
Kaplan-Meier Estimate
Male
Posterior Leukoencephalopathy Syndrome / etiology*
Proportional Hazards Models
Risk Factors
Syndrome
Transplantation, Homologous
Treatment Outcome